2021
DOI: 10.1099/mic.0.000997
|View full text |Cite
|
Sign up to set email alerts
|

Lox’d in translation: contradictions in the nomenclature surrounding common lox-site mutants and their implications in experiments

Abstract: The Cre-Lox system is a highly versatile and powerful DNA recombinase mechanism, mainly used in genetic engineering to insert or remove desired DNA sequences. It is widely utilized across multiple fields of biology, with applications ranging from plants, to mammals, to microbes. A key feature of this system is its ability to allow recombination between mutant lox sites. Two of the most commonly used mutant sites are named lox66 and lox71, which recombine to create a functionally inactive double mutant lox72 si… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 63 publications
(89 reference statements)
0
3
0
Order By: Relevance
“…The first template was made of (i) a centromere (CEN6), an autonomously replicating sequence (ARSH4), and the HIS3 selection marker for selection in yeast, (ii) a gentamicin resistance marker for selection in mycoplasma cells, and (iii) 60 bp recombination arms placed at each extremity, identical to the sequences flanking the target gene. The second template was indistinguishable from the first except for the presence of two 34 bp loxP sites [ 55 ] flanking the Cre targets, i.e. the gentamicin resistance marker and the yeast components that must be removed to obtain seamless mutants (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The first template was made of (i) a centromere (CEN6), an autonomously replicating sequence (ARSH4), and the HIS3 selection marker for selection in yeast, (ii) a gentamicin resistance marker for selection in mycoplasma cells, and (iii) 60 bp recombination arms placed at each extremity, identical to the sequences flanking the target gene. The second template was indistinguishable from the first except for the presence of two 34 bp loxP sites [ 55 ] flanking the Cre targets, i.e. the gentamicin resistance marker and the yeast components that must be removed to obtain seamless mutants (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…S1, available in the online version of this article) using the primer pairs MccpPeptS41pMT85gentPRS-F/MccpPeptS41pMT85gentPRS-F. The second one was produced with the primer pairs MccpPeptS41LOX66pMT85gentPRS-F/MccpPeptS41LOX71pMT85gentPRS-R in order to include loxP sites [ 55 ] in the amplicon (Fig. S2).…”
Section: Methodsmentioning
confidence: 99%
“…The RBEs are separated by an 8-bp asymmetric spacer that determines the orientation of each site, and the outcome of a recombination reaction. [8][9][10][11] Four molecules of Cre assemble with two loxP DNA sites and, in alternating fashion, tyrosine residues of each protomer perform a series of strand cleavages, exchanges and ligations, forming covalent 3'-phosphotyrosine and Holliday junction intermediates in order to generate recombinant products. Cre catalyzes this reaction without the need of additional factors or consumption of ATP, and thus, has emerged as a powerful tool for genome engineering in the laboratory.…”
Section: Introductionmentioning
confidence: 99%